FTC Seeks More Info On $5.2B Watson, Actavis Merger
Watson Pharmaceuticals Inc. said Thursday that the Federal Trade Commission has asked for further information about its €4.25 billion ($5.2 billion) plan to buy Swiss drugmaker Actavis Group as the agency...To view the full article, register now.
Already a subscriber? Click here to view full article